Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
10.3%
% of GDOC's 41 holdings also in MEDX
13.3%
% of MEDX's 30 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.5% | 17.2% | 9.5% |
|
ABBVIE INC | 5.7% | 8.6% | 5.7% |
|
MERCK & CO. INC. | 4.2% | 4.3% | 4.2% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 4.4% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to MEDX
|
BOSTON SCIENTIFIC CORP | 7.8% |
|
INTUITIVE SURGICAL INC | 6.0% |
|
UNITEDHEALTH GROUP INC | 6.0% |
|
INSULET CORP | 5.9% |
|
COOPER COS INC/THE | 4.1% |
|
ABBOTT LABORATORIES | 4.1% |
 |
NOVO NORDISK A/S-B | 3.8% |
|
DANAHER CORP | 3.6% |
 |
ASTRAZENECA PLC | 3.2% |
|
BIOMARIN PHARMACEUTICAL INC | 2.9% |
GDOC Underweight Relative to MEDX
|
ELI LILLY & CO | -7.7% |
|
BRISTOL-MYERS SQUIBB CO | -6.4% |
 |
NOVARTIS AG-ADR | -6.1% |
|
AMGEN INC | -5.6% |
|
ASTRAZENECA PLC-SPONS ADR | -5.4% |
|
JOHNSON & JOHNSON | -4.7% |
|
PFIZER INC | -4.4% |
 |
ALKERMES PLC | -4.1% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
BIOGEN IDEC INC | -3.0% |